TITLE:
Pemetrexed as First Line Chemotherapy for Advanced Breast Cancer

CONDITION:
Breast Cancer

INTERVENTION:
pemetrexed

SUMMARY:

      The purposes of this study are to determine the safety of pemetrexed and any side effects
      that might be associated with it, whether pemetrexed can help patients with breast cancer
      and how much pemetrexed should be given to patients.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Inclusion Criteria:

          -  Be at least 18 years of old.

          -  Have been diagnosed with breast cancer

          -  At least one year disease-free interval after initial treatment.

          -  Have pre-study laboratory tests that are within the requirements of this study.

          -  Be able to visit the doctor's office weekly during the treatment period.

        Exclusion Criteria:

          -  To be pregnant or breastfeeding.

          -  To be currently taking aspirin or aspirin- like medicine and unable to stop for a few
             days during each cycle of therapy.

          -  To have received prior chemotherapy for the treatment of metastatic cancer. Patients
             may have received prior hormonal treatment.

          -  To have another illness that your doctor thinks would make you unable to participate.

          -  To be unable or not willing to take folic acid and vitamin B12.
      
